'Instant' blood test for heart attacks developed

Image
Press Trust of India London
Last Updated : Sep 28 2017 | 4:42 PM IST
Scientists have developed a revolutionary new blood test for detecting a heart attack that could speed up diagnosis and help patients get out of hospital more quickly.
The test, developed by researchers from King's College London and tested across Europe, is quicker than the standard test and can rapidly rule out a heart attack in more people.
Currently, people suspected of having a heart attack are tested for high levels of a protein called troponin in their blood as soon as they arrive in an emergency department, and again after three hours researchers said.
Depending on the type of troponin test used, up to 85 per cent of people need to remain in hospital for further tests in order to rule out a heart attack, they said.
The new test uses similar technology to the troponin test, but analyses the level of a protein called cardiac myosin-binding protein C (cMyC).
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin, meaning that the test can rule out a heart attack in a higher proportion of patients straight away.
"Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging," said Professor Nilesh Samani, Medical Director at the British Heart Foundation.
"The troponin test has been used for around 20 years and is currently the most powerful tool we have for diagnosing such heart attacks, but there is always room for improvement," said Samani, who described the potential importance of the new test in the journal Circulation.
"These initial results with the cMyC test look very promising for patients, who could be more quickly diagnosed and treated or reassured and sent home.
"This test could also allow hospitals to save hundreds of thousands of pounds by freeing up valuable hospital beds. However further research is necessary before it can be recommended as a replacement for the troponin test," he said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 28 2017 | 4:42 PM IST

Next Story